Other financings of public biotechnology companies: November 2004.

 Other Financings Of Public Biotechnology Companies: November 2004  TOTAL: $2,314.04M  Company              Type Of           Number Of         Amount (Symbol) (#)         Financing         Shares, Units     Raised                                        Or Warrants (M)   (M)  Acrongenomics        Private           0.4S              $1 Inc. (OTC BB:        placement of AGNM)                stock  Active Biotech       Private           N/A               SEK150 AB (Sweden;          placement of                        (US$21.4) SSE:ACTI)            convertible                      debentures  American             Private           6S and            $6 Oriental             placement of      9W Bioengineering       stock and Inc. (China;         warrants OTC BB:AOBO)  Amgen Inc.           Private           N/A               $2,000 (AMGN)               placement of                      notes  Australian           Rights issue      ND                A$4 Cancer                                                   (US$3) Technology Ltd. (Australia; ASX:ACU)  Cell Genesys         Private           N/A               $35 Inc. (CEGE)          placement of                      convertible                      notes  Dyadic               Private           ND                $25.3 International        placement of Inc. (OTC BB:        stock DYAD)  Elite                Private           0.517S and        $6.6 Pharmaceuticals      placement of      5.17W Inc. (AMEX:ELI)      preferred stock                      and warrants  Genaera Corp.        Private           4.18S             $14.4 (GENR)               placement                      of stock  Genaissance          Private           3.55S and         $6 Pharmaceuticals      placement of      3.55W Inc. …